LLY
Eli Lilly and Company · Healthcare · Drug Manufacturers - General
Señales de momentum (gestores comparables): amplitud de titulares 0.0% · flujo de acciones -3.2% · nuevas posiciones netas 0.0% · fórmula
Todas las cifras de propiedad: únicamente gestores 13F seguidos, posiciones en acciones ordinarias, período de referencia Q1 2025
| Trimestre | Titulares | Δ | Acciones | Valor declarado | Nuevo | Cierres |
|---|---|---|---|---|---|---|
| Q2 2026 | 191 | +4 | 666.78M | $798.87B | +6 | −3 |
| Q1 2026 | 191 | -3 | 666.59M | $613.20B | +1 | −5 |
| Q4 2025 | 193 | +2 | 707.04M | $758.81B | +3 | n/a |
| Q3 2025 | 27 | -3 | 329.88M | $251.63B | +2 | −6 |
| Q2 2025 | 28 | -1 | 307.45M | $239.60B | +2 | −3 |
| Q1 2025 | 26 | 0 | 140.32M | $115.83B | +1 | −1 |
| Q4 2024 | 26 | +1 | 145.00M | $111.91B | +3 | −2 |
| Q3 2024 | 24 | +2 | 109.89M | $97.29B | +2 | n/a |
| Q2 2024 | 22 | n/a | 112.43M | $101.75B | n/a | n/a |
| # | Gestor | Acciones | Δ acciones | Valor | Su ponderación | Mantenida | ||
|---|---|---|---|---|---|---|---|---|
| 1 | State Street Global Advisors ✦ (pasivo) | 34.44M | +0.4% | $28.44B | 1.2% | ▲ Add | 2 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 19.13M | -8.3% | $15.80B | 2.0% | ▼ Trim | 4 | SEC ↗ ×2 |
| 3 | Geode Capital Management ✦ (pasivo) | 18.53M | +6.6% | $15.25B | 1.2% | ▲ Add | 4 | SEC ↗ ×2 |
| 4 | Capital World Investors ✦ | 18.38M | -6.0% | $15.18B | 2.5% | ▼ Trim | 4 | SEC ↗ |
| 5 | PRIMECAP Management ✦ | 14.78M | -11.8% | $12.21B | 10.1% | ▼ Trim | 4 | SEC ↗ |
| 6 | Wellington Management ✦ | 12.71M | +0.7% | $10.50B | 2.0% | ▲ Add | 4 | SEC ↗ ×9 |
| 7 | Norges Bank ✦ (pasivo) | 11.00M | +1.0% | $9.08B | 1.3% | ▲ Add | 4 | SEC ↗ |
| 8 | Fisher Asset Management ✦ | 5.44M | +3.9% | $4.49B | 1.9% | ▲ Add | 4 | SEC ↗ |
| 9 | Tiger Global Management ✦ | 1.33M | +1.9% | $1.10B | 4.1% | ▲ Add | 4 | SEC ↗ |
| 10 | Adage Capital Partners ✦ | 741.72K | +1.2% | $612.60M | 1.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Millennium Management ✦ | 681.01K | -15.0% | $562.46M | 0.6% | ▼ Trim | 4 | SEC ↗ |
| 12 | D. E. Shaw & Co. ✦ | 573.33K | -53.8% | $473.52M | 0.6% | ▼ Trim | 4 | SEC ↗ ×2 |
| 13 | AQR Capital Management ✦ | 567.50K | -11.9% | $456.15M | 0.5% | ▼ Trim | 4 | SEC ↗ ×7 |
| 14 | Lone Pine Capital ✦ | 551.83K | -29.5% | $455.76M | 4.0% | ▼ Trim | 2 | SEC ↗ |
| 15 | Citadel Advisors ✦ | 477.78K | -21.8% | $394.60M | 0.4% | ▼ Trim | 4 | SEC ↗ ×2 |
| 16 | Marshall Wace ✦ | 419.50K | +7.9% | $346.47M | 0.5% | ▲ Add | 4 | SEC ↗ ×4 |
| 17 | Coatue Management ✦ | 183.72K | -14.1% | $151.74M | 0.7% | ▼ Trim | 4 | SEC ↗ ×5 |
| 18 | Renaissance Technologies ✦ | 96.31K | +78.0% | $79.55M | 0.1% | ▲ Add | 3 | SEC ↗ |
| 19 | Duquesne Family Office ✦ | 94.83K | +52.5% | $78.32M | 2.6% | ▲ Add | 2 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 54.77K | Nuevo | $45.24M | 0.1% | New | 1 | SEC ↗ |
| 21 | Dodge & Cox ✦ | 45.09K | +0.7% | $37.24M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 22 | Arrowstreet Capital ✦ | 41.41K | +178.9% | $34.20M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 23 | GAMCO Investors ✦ | 30.07K | -10.3% | $24.84M | 0.3% | ▼ Trim | 4 | SEC ↗ |
| 24 | Two Sigma Investments ✦ | 15.73K | -95.1% | $12.99M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 25 | Gotham Asset Management ✦ | 7.55K | +30.6% | $6.23M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 26 | Bridgewater Associates ✦ | 2.75K | -96.7% | $2.27M | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Their weight" = la participación de la posición en el valor de renta variable 13F reportado por ese manager: la medida de convicción. ✦ = manager curado.
Nuevos compradores
| Point72 Asset Management | $45.24M | 0.1% |
Posición cerrada
| Soros Fund Management | $25.97M | era 0.7% |
Contexto de mercado completo: entre TODOS los filers 13F (datos estructurados SEC, Q1 2026): 4,323 tenedores, 762.84M acciones, $674.93B declarado. Este es un período diferente y anterior al de las cifras del universo rastreado que figuran arriba, y ambos nunca se mezclan.
Qué más suelen tener los titulares rastreados de este valor: recuentos de titularidad compartida, no relaciones fundamentales.
Compras en mercado abierto (P)
Sin compras en mercado abierto por parte de insiders en nuestra ventana de cobertura.
Ventas en mercado abierto (S)
Officer · 6.50K acc. · $7.64M
Officer · 2.00K acc. · $2.37M
Officer · 5.00K acc. · $5.95M
Las adjudicaciones, ejercicios y retenciones fiscales nunca se contabilizan aquí como compras o ventas. Metodología